Hiroki Kurata
Overview
Explore the profile of Hiroki Kurata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
229
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matsuda T, Yamada S, Tsuchiyama A, Kurata H, Mukae Y, Okano S, et al.
IJU Case Rep
. 2025 Mar;
8(2):142-145.
PMID: 40034899
Introduction: Desmoid tumors are rare, locally invasive, non-metastasizing intermediate grade neoplasms. According to the organ procurement and transplantation network report, approximately one million solid organ transplants have been performed globally,...
2.
Sadahira T, Sekito T, Maruyama Y, Ichikawa T, Kurihara Y, Shiraishi H, et al.
Urology
. 2024 Dec;
196:32-39.
PMID: 39694101
Objective: To examine whether antimicrobial prophylaxis based on screening rectal cultures using selective media prevented acute bacterial prostatitis following transrectal prostate biopsy (TRPB). Methods: In this multicenter, randomized controlled trial,...
3.
Mitsunari K, Fukushima H, Kurata H, Harada J, Nakamura Y, Matsuo T, et al.
Anticancer Res
. 2024 Jun;
44(7):3149-3154.
PMID: 38925837
Background/aim: The primary objective of this study was to identify predictors for biochemical recurrence (BCR) within 2 years following robot-assisted radical prostatectomy (RARP). Identifying predictors will enable insights that enhance...
4.
Mitsunari K, Kurata H, Ito I, Harada J, Nakamura Y, Matsuo T, et al.
Transplant Proc
. 2024 Feb;
56(2):285-289.
PMID: 38320870
Background: Prostate cancer is common among male renal transplant recipients and can present challenges for medical management and patient survival. It is imperative to have a comprehensive understanding of available...
5.
Takekuma H, Sato R, Iida K, Kawawaki T, Haruta M, Kurata H, et al.
Adv Sci (Weinh)
. 2024 Jan;
11(10):e2307055.
PMID: 38196298
Materials that intrinsically exhibit localized surface plasmon resonance (LSPR) in the visible region have been predominantly researched on nanoparticles (NPs) composed of coinage metals, namely Au, Ag, and Cu. Here,...
6.
Matsushima T, Mitsunari K, Maekawa N, Yamada S, Ito H, Kurata H, et al.
IJU Case Rep
. 2023 Nov;
6(6):394-397.
PMID: 37928290
Introduction: Cholesterol crystal embolism is a rare microembolic disease caused by cholesterol crystals that can present with various symptoms after vascular surgery, catheterization, or anticoagulation therapy. We report a case...
7.
Pimta K, Autthawong T, Yodying W, Phromma C, Haruta M, Kurata H, et al.
ACS Omega
. 2023 May;
8(17):15360-15370.
PMID: 37151525
Bronze phase titanium dioxide (TiO(B)) nanorods were successfully prepared via a hydrothermal method together with an ion exchange process and calcination by using anatase titanium dioxide precursors in the alkali...
8.
Iwashimizu C, Haruta M, Nemoto T, Kurata H
Microscopy (Oxf)
. 2022 Nov;
72(4):353-360.
PMID: 36440709
High-angle annular dark-field (HAADF) imaging and elemental mapping at the atomic scale by scanning transmission electron microscopy (STEM) combined with electron energy-loss spectroscopy (EELS) are widely used for material characterization,...
9.
Matsumoto K, Sato R, Trinh T, Sakuma N, Shoji T, Haruta M, et al.
Nanoscale Adv
. 2022 Sep;
1(7):2598-2605.
PMID: 36132735
Conceptual nanocomposite magnets (NCMs) composed of exchange-coupled hard/soft magnetic phases have been expected to show excellent magnetic performance based on simultaneous high coercivity ( ) and high saturation magnetization (...
10.
Ito H, Matsuo T, Kurata H, Masato M, Mitsunari K, Ohba K, et al.
In Vivo
. 2022 Jun;
36(4):1847-1853.
PMID: 35738641
Background/aim: In clinical practice, constipation is one of the most frequent adverse events caused by drugs for overactive bladder (OAB). The occurrence of constipation greatly deteriorates the patient's quality of...